Leukemia Incidence and Mortality by Year, White Individuals, New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 689 11.9 11.0-12.9 383 15.8 14.2-17.6 306 9.1 8.0-10.2 500 8.7 8.0-9.6 263 11.2 9.8-12.7 237 7.0 6.1-8.0
1977 640 11.2 10.3-12.1 348 14.5 12.9-16.2 292 8.8 7.7-9.9 458 8.0 7.3-8.8 254 10.8 9.5-12.3 204 6.1 5.3-7.1
1978 686 12.1 11.2-13.1 394 16.8 15.1-18.7 292 8.9 7.8-10.0 463 8.1 7.4-8.9 250 10.7 9.4-12.1 213 6.4 5.6-7.4
1979 646 11.5 10.6-12.5 329 13.8 12.3-15.5 317 9.9 8.8-11.1 467 8.3 7.6-9.2 238 10.2 8.9-11.7 229 7.2 6.2-8.2
1980 741 13.4 12.5-14.5 379 16.6 14.9-18.4 362 11.4 10.2-12.7 436 7.8 7.1-8.6 252 11.2 9.8-12.7 184 5.6 4.7-6.5
1981 655 11.9 11.0-12.9 362 16.0 14.3-17.7 293 9.1 8.0-10.2 450 8.2 7.4-9.0 245 10.8 9.5-12.3 205 6.4 5.5-7.4
1982 692 12.6 11.7-13.6 383 17.1 15.4-18.9 309 9.5 8.4-10.7 474 8.7 7.9-9.6 264 12.0 10.5-13.5 210 6.5 5.6-7.5
1983 648 12.2 11.3-13.2 328 14.8 13.2-16.5 320 10.7 9.5-12.1 419 7.8 7.1-8.6 224 10.4 9.0-11.9 195 6.1 5.2-7.1
1984 688 12.7 11.8-13.8 371 17.3 15.5-19.2 317 9.9 8.8-11.1 458 8.4 7.6-9.2 241 11.2 9.8-12.8 217 6.5 5.6-7.5
1985 650 11.9 11.0-12.9 353 16.1 14.4-17.9 297 9.2 8.1-10.4 407 7.4 6.7-8.2 204 9.4 8.1-10.8 203 6.1 5.3-7.1
1986 699 13.2 12.2-14.3 354 15.9 14.3-17.7 345 11.5 10.2-12.8 405 7.5 6.8-8.3 202 9.2 7.9-10.6 203 6.3 5.5-7.3
1987 560 10.6 9.7-11.5 266 12.5 11.0-14.1 294 9.3 8.3-10.5 358 6.6 5.9-7.3 172 8.0 6.8-9.3 186 5.9 5.0-6.8
1988 599 11.6 10.7-12.6 313 15.0 13.4-16.8 286 9.4 8.3-10.6 353 6.7 6.0-7.5 192 9.2 7.9-10.6 161 5.1 4.3-6.0
1989 679 13.1 12.1-14.2 362 17.3 15.6-19.3 317 10.4 9.2-11.6 366 6.9 6.2-7.7 192 9.2 8.0-10.7 174 5.4 4.6-6.3
1990 690 13.7 12.7-14.8 361 17.3 15.5-19.2 329 11.3 10.0-12.6 361 7.0 6.3-7.8 181 9.0 7.7-10.4 180 5.9 5.0-6.9
1991 627 12.8 11.8-13.8 350 17.1 15.3-19.0 277 9.5 8.3-10.7 355 7.0 6.3-7.8 208 10.4 9.0-12.0 147 4.8 4.0-5.7
1992 642 12.9 11.9-14.0 352 17.3 15.5-19.2 290 10.0 8.8-11.2 324 6.4 5.7-7.2 178 9.0 7.7-10.4 146 4.8 4.0-5.7
1993 601 12.3 11.3-13.3 293 14.3 12.7-16.1 308 11.0 9.8-12.4 336 6.6 5.9-7.4 190 9.3 8.0-10.7 146 4.9 4.2-5.9
1994 698 14.1 13.1-15.2 357 17.7 15.9-19.7 341 11.5 10.3-12.9 387 7.6 6.9-8.4 197 9.7 8.4-11.2 190 6.1 5.2-7.0
1995 619 12.7 11.7-13.8 318 15.7 14.0-17.6 301 10.6 9.4-11.9 378 7.6 6.8-8.4 199 10.0 8.7-11.5 179 6.0 5.1-6.9
1996 628 12.9 11.9-14.0 349 17.2 15.4-19.1 279 9.9 8.7-11.2 340 6.8 6.1-7.5 165 8.1 6.9-9.5 175 5.9 5.1-6.9
1997 668 13.7 12.7-14.8 355 17.6 15.8-19.5 313 11.1 9.9-12.5 346 7.0 6.3-7.8 199 10.0 8.7-11.5 147 4.9 4.1-5.8
1998 657 13.4 12.4-14.5 363 17.6 15.8-19.5 294 10.3 9.1-11.6 362 7.3 6.6-8.1 205 10.0 8.7-11.5 157 5.3 4.5-6.3
1999 736 14.9 13.9-16.1 385 18.7 16.9-20.7 351 12.2 10.9-13.6 370 7.3 6.6-8.1 203 9.9 8.6-11.4 167 5.6 4.7-6.5
2000 674 13.7 12.6-14.7 343 16.6 14.9-18.5 331 11.6 10.3-12.9 329 6.5 5.8-7.3 149 7.2 6.1-8.4 180 6.0 5.1-7.0
2001 703 14.2 13.1-15.3 358 17.3 15.5-19.2 345 12.0 10.7-13.4 344 6.7 6.0-7.5 176 8.5 7.3-9.9 168 5.4 4.6-6.3
2002 637 12.8 11.8-13.9 360 17.2 15.4-19.0 277 9.6 8.5-10.9 342 6.7 6.0-7.4 178 8.6 7.4-10.0 164 5.4 4.6-6.3
2003 725 14.7 13.6-15.8 373 17.8 16.0-19.7 352 12.4 11.1-13.9 309 6.1 5.4-6.8 162 7.8 6.6-9.1 147 4.9 4.2-5.9
2004 694 13.9 12.9-15.0 366 17.6 15.8-19.5 328 11.4 10.2-12.8 354 6.9 6.2-7.7 185 9.0 7.8-10.4 169 5.6 4.8-6.5
2005 722 14.7 13.7-15.9 407 19.3 17.5-21.3 315 11.3 10.1-12.7 345 6.8 6.1-7.6 193 9.3 8.0-10.7 152 5.1 4.3-6.0
2006 698 14.4 13.4-15.6 381 18.4 16.6-20.4 317 11.5 10.2-12.9 344 6.8 6.1-7.6 177 8.6 7.4-10.0 167 5.6 4.8-6.6
2007 742 15.5 14.4-16.7 414 19.8 17.9-21.8 328 12.3 10.9-13.7 325 6.5 5.8-7.3 178 8.7 7.4-10.1 147 5.3 4.4-6.2
2008 739 15.4 14.3-16.5 409 19.8 17.9-21.8 330 12.2 10.9-13.6 347 7.0 6.3-7.8 171 8.3 7.1-9.7 176 6.2 5.3-7.2
2009 809 16.6 15.5-17.8 434 20.6 18.7-22.7 375 13.5 12.1-15.0 316 6.3 5.6-7.1 143 6.9 5.8-8.1 173 5.9 5.0-6.9
2010 836 17.0 15.9-18.3 470 22.1 20.1-24.2 366 13.1 11.7-14.6 327 6.4 5.7-7.2 178 8.5 7.3-9.9 149 5.0 4.2-6.0
2011 853 16.9 15.8-18.1 467 21.4 19.5-23.5 386 13.7 12.3-15.2 340 6.5 5.8-7.3 197 9.3 8.0-10.7 143 4.5 3.8-5.4
2012 792 15.7 14.6-16.8 460 20.8 19.0-22.9 332 11.9 10.6-13.3 311 5.9 5.3-6.7 176 8.2 7.0-9.5 135 4.3 3.6-5.2
2013 838 16.5 15.4-17.7 487 22.1 20.2-24.2 351 12.3 11.0-13.7 342 6.6 5.9-7.3 196 9.0 7.8-10.4 146 4.9 4.1-5.8
2014 892 17.6 16.4-18.8 463 20.8 18.9-22.8 429 15.3 13.8-16.9 293 5.5 4.9-6.2 148 6.8 5.7-8.0 145 4.7 3.9-5.5
2015 912 17.6 16.5-18.8 523 23.0 21.1-25.1 389 13.4 12.0-14.8 330 6.1 5.5-6.8 182 8.2 7.0-9.5 148 4.7 3.9-5.5
2016 869 16.5 15.4-17.7 512 22.1 20.2-24.1 357 12.2 11.0-13.6 322 5.9 5.3-6.6 160 7.0 6.0-8.2 162 5.3 4.5-6.2
2017 814 15.6 14.5-16.7 463 19.8 18.0-21.7 351 12.4 11.1-13.8 298 5.3 4.7-5.9 153 6.5 5.5-7.7 145 4.4 3.7-5.3
2018 792 15.3 14.3-16.5 460 19.9 18.1-21.8 332 11.5 10.3-12.9 276 4.9 4.3-5.6 143 5.9 5.0-7.0 133 4.2 3.5-5.0
2019 726 13.8 12.8-14.9 412 17.5 15.9-19.4 314 10.7 9.5-12.0 312 5.6 5.0-6.3 170 7.3 6.2-8.5 142 4.4 3.7-5.2
2020 706 13.5 12.5-14.6 403 17.2 15.6-19.0 303 10.6 9.4-12.0 256 4.6 4.0-5.2 151 6.4 5.4-7.5 105 3.3 2.7-4.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.